This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.
Rezensionen / Stimmen
"This book is a collection of national case studies about pharmaceutical pricing policy. . this book offers a wealth of examples to consider, especially for low- and middle-income countries that are in the process of changing or establishing health insurance programs. Having a consolidated reference source, such as this book, for academics interested in the field of policy analysis will obviously be very useful." (Suzanne Rose Hill, PharmacoEconomics, Vol. 34 (3), March, 2016)
Auflage
Softcover reprint of the original 1st ed. 2015
Sprache
Verlagsort
Verlagsgruppe
Springer International Publishing
Zielgruppe
Illustrationen
34
3 s/w Abbildungen, 34 farbige Abbildungen
X, 411 p. 37 illus., 34 illus. in color.
Maße
Höhe: 235 mm
Breite: 155 mm
Dicke: 23 mm
Gewicht
ISBN-13
978-3-319-35009-7 (9783319350097)
DOI
10.1007/978-3-319-12169-7
Schweitzer Klassifikation
